Login / Signup

Incidence and clinical predictors of infections in patients treated with severe systemic ANCA-associated vasculitis.

Agnès HarisK PolnerJ ArányiH BraunitzerI Kaszás
Published in: Physiology international (2021)
Advanced renal failure, pulmonary involvement and high degree of comorbidities increase the risk of infection in AAV. Those who suffer infection during induction immunosuppression have worse long-term survival. Our findings indicate the need for high vigilance for infections and close follow-up of comorbidities when treating AAV.
Keyphrases
  • gene therapy
  • pulmonary hypertension
  • risk factors
  • early onset
  • drug induced